Author

B. Przychodzen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Berezovsky· 1 shared B. A. Bell· 1 shared B. K. Jha· 1 shared D. J. Silver· 1 shared E. E. Mulkearns-Hubert· 1 shared E. Serbinowski· 1 shared J. D. Lathia· 1 shared J. S. Hale· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Berezovsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Amantadine disrupts lysosomal gene expression; potential therapy for COVID19

S. Smieszek, B. Przychodzen, M. H. Polymeropoulos

This study identifies amantadine as a compound that downregulates CTSL/CTSB gene expression and disrupts the lysosomal pathway, potentially inhibiting SARS-CoV-2 replication.

bioRxiv · Apr 5, 2020 · PreprintMicrobiology

Development of a Cx46 targeting strategy for cancer stem cells

E. E. Mulkearns-Hubert, L. A. Torre-Healy, D. J. Silver, J. T. Eurich, E. Serbinowski, M. Hitomi, J. Zhou, B. Przychodzen, R. Zhang, S. A. Sprowls, J. S. Hale, T. Alban, A. Berezovsky, B. A. Bell, P. R. Lockman, , J. D. Lathia

This study identifies clofazimine as a Cx46 inhibitor that targets glioblastoma cancer stem cells by disrupting gap junction communication, enhancing the efficacy of temozolomide.

bioRxiv · Mar 26, 2018Cancer Biology